(19)
(11) EP 1 171 097 A1

(12)

(43) Date of publication:
16.01.2002 Bulletin 2002/03

(21) Application number: 00921288.7

(22) Date of filing: 06.04.2000
(51) International Patent Classification (IPC)7A61K 9/00, A61K 47/00, A61K 31/66
(86) International application number:
PCT/SE0000/664
(87) International publication number:
WO 0061/111 (19.10.2000 Gazette 2000/42)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 09.04.1999 SE 9901272

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • LINDFORS, Lennart
    S-431 83 Mölndal (SE)
  • LÖFROTH, Jan-Erik
    S-431 83 Mölndal (SE)
  • SJÖGREN, Sven
    S-431 83 Mölndal (SE)
  • UNGELL, Anna-Lena
    S-431 83 Mölndal (SE)

   


(54) A PHARMACEUTICAL FORMULATION COMPRISING AN BISPHOSPHONATE AND AN ADDITIVE AGENT PROVIDING AN ENHANCED ABSORPTION OF THE BISPHOSPHONATE